Tested Applications
| Positive WB detected in | HEK-293 cells, HeLa cells, HepG2 cells |
| Positive IP detected in | HEK-293 cells |
| Positive IHC detected in | human testis tissue, human cervical cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HepG2 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:5000-1:50000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:200-1:800 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
24563-1-AP targets NCAPG in WB, IHC, IF/ICC, IP, CoIP, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag19926 Product name: Recombinant human NCAPG protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 664-1015 aa of BC068467 Sequence: TLHCEGTEINSDDEQESKEVEETATAKNVLKLLSDFLDSEVSELRTGAAEGLAKLMFSGLLVSSRILSRLILLWYNPVTEEDVQLRHCLGVFFPVFAYASRTNQECFEEAFLPTLQTLANAPASSPLAEIDITNVAELLVDLTRPSGLNPQAKTSQDYQALTVHDNLAMKICNEILTSPCSPEIRVYTKALSSLELSSHLAKDLLVLLNEILEQVKDRTCLRALEKIKIQLEKGNKEFGDQAEAAQDATLTTTTFQNEDEKNKEVYMTPLRGVKATQASKSTQLKTNRGQRKVTVSARTNRRCQTAEADSESDHEVPEPESEMKMRLPRRAKTAALEKSKLNLAQFLNEDLS Predict reactive species |
| Full Name | non-SMC condensin I complex, subunit G |
| Calculated Molecular Weight | 1015 aa, 114 kDa |
| Observed Molecular Weight | 131 kDa |
| GenBank Accession Number | BC068467 |
| Gene Symbol | NCAPG |
| Gene ID (NCBI) | 64151 |
| RRID | AB_2879610 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9BPX3 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for NCAPG antibody 24563-1-AP | Download protocol |
| IHC protocol for NCAPG antibody 24563-1-AP | Download protocol |
| IP protocol for NCAPG antibody 24563-1-AP | Download protocol |
| WB protocol for NCAPG antibody 24563-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The NCAPG Polyclonal antibody (Cat. 24563-1-AP) has 12 total citations. It appears in journals including Journal of Nanobiotechnology, Cell Death & Disease, Journal of Translational Medicine, Breast Cancer Research, International Journal of Molecular Sciences, Frontiers in Pharmacology, Scientific Reports, Frontiers in Oncology, Journal of Cancer, Journal of Gastrointestinal Oncology, and International Journal of Biological Sciences. The research fields center on oncology, covering breast, hepatocellular, prostate, neuroblastoma, non-small cell lung, glioma, colorectal, and endometrial cancers, plus liver regeneration and cancer-associated fibroblast studies, validated via WB, IHC, IF, and CoIP.
| Species | Application | Title |
|---|---|---|
J Nanobiotechnology Hepatocyte-derived tissue extracellular vesicles safeguard liver regeneration and support regenerative therapy | ||
Cell Death Dis NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer.
| ||
J Transl Med NCAPG promotes the proliferation of hepatocellular carcinoma through the CKII-dependent regulation of PTEN.
| ||
J Transl Med Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance | ||
Breast Cancer Res Integrated multi-omics analysis and functional validation reveal the role of TRIM2 as a potential novel biomarker in breast cancer. | ||
Int J Mol Sci Identification of NCAPG as an Essential Gene for Neuroblastoma Employing CRISPR-Cas9 Screening Database and Experimental Verification
|























